Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042367 · ClinicalTrials.gov registry record · NA
Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors
A NA study of Brain Tumors, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 3
- Study locations
NCT00042367 is a NA study of Brain Tumors that has completed, run by Baylor College of Medicine. The registered enrollment target is 119 participants, below the 6,331-participant average among 10 other Brain Tumors trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00042367, a NA study of Brain Tumors, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purposes of this study are to find the highest dose of mafosfamide that can be given without causing severe side effects, to see how well the combination of these chemotherapy drugs and lower doses of radiation work to delay or stop the growth of the tumor, and to evaluate the pharmacokinetics (how the body handles) of Mafosfamide.
Conditions Studied
Interventions
- DRUG Induction therapy (Regimen 1, Course 1, Cycle A1
- DRUG Regimen 1, Course 1, Cycle A2 (Days 22 - 42)
- DRUG Cycle B
- DRUG Regimen 1, Course 2
- DRUG Intrathecal Mafosfamide
Study Locations (3)
North Carolina
- Brain Tumor Center at Duke University - Durham
Tennessee
- St. Jude Children's Research Hospital - Memphis
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2000-04-04 |
| Est. Completion | 2006-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00042367
The ClinicalTrials.gov registry entry for NCT00042367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,331-participant average among 10 other Brain Tumors trials with a reported enrollment target (98% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Tumors appearing as the primary indexed condition, and to 5 interventions - of which Induction therapy (Regimen 1, Course 1, Cycle A1 is the first listed.
NCT00042367 reports 3 study locations spanning 3 distinct geographic areas - top geographies include North Carolina, Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT00042367 about?
NCT00042367 is a clinical study titled "Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors". The purposes of this study are to find the highest dose of mafosfamide that can be given without causing severe side effects, to see how well the combination of these chemotherapy drugs and lower doses of radiation work to delay or stop the growth of the tumor, and to evaluate the pharmacokinetics (...
What is the current status of trial NCT00042367?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2000-04-04. Estimated completion is 2006-06.
What conditions does trial NCT00042367 study?
This clinical trial studies the following conditions: Brain Tumors.
What interventions are being tested in trial NCT00042367?
The interventions under investigation include: Induction therapy (Regimen 1, Course 1, Cycle A1 (DRUG), Regimen 1, Course 1, Cycle A2 (Days 22 - 42) (DRUG), Cycle B (DRUG), Regimen 1, Course 2 (DRUG), Intrathecal Mafosfamide (DRUG).
Who is sponsoring clinical trial NCT00042367?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00042367 being conducted?
This trial has 3 study locations across North Carolina, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Florida Center for Brain Tumor Research
RECRUITING
-
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
ACTIVE NOT RECRUITING
-
Blood Flow MRI for Monitoring Brain Tumors
ACTIVE NOT RECRUITING
-
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
ACTIVE NOT RECRUITING
-
ALA-induced PpIX Fluorescence During Brain Tumor Resection
ACTIVE NOT RECRUITING · Phase 1
-
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.